The connected medical device market size is expected to see rapid growth in the next few years. It will grow to $117.68 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to expansion of wearable and implantable medical devices, rising investment in telehealth and remote monitoring, integration with artificial intelligence for predictive insights, growth in home care and long-term care adoption, increasing regulatory support for connected medical devices. Major trends in the forecast period include integration of connected devices with electronic health records (ehrs), increasing adoption of remote patient monitoring solutions, growth in chronic disease management programs, enhanced data analytics for clinical decision support, rising focus on home-based healthcare and telemedicine.
The growing adoption of telemedicine services is expected to drive the growth of the connected medical device market in the coming years. Telemedicine involves using technology to deliver medical care and consultations remotely, eliminating the need for in-person visits. Its increasing demand is driven by the convenience it offers, allowing patients to consult healthcare providers quickly from home, saving time and reducing travel. The expansion of telemedicine supports the use of connected medical devices by enabling remote patient monitoring, which relies on real-time data transmission to healthcare providers for accurate diagnosis and timely interventions without physical visits. For example, in April 2025, according to the American Hospital Association, a US-based nonprofit trade organization, over 12.6% of Medicare beneficiaries received a telehealth service in the last quarter of 2023. Additionally, the United States is projected to face a physician shortage of up to 86,000 by 2036, making telehealth a critical tool to mitigate the impact of this shortage. Therefore, the rise of telemedicine services is driving the growth of the connected medical device market.
Major companies in the connected medical device market are increasingly focusing on developing advanced AI-powered platforms that enable personalized user experiences by adapting in real-time to individual behaviors and preferences. AI-powered platforms leverage artificial intelligence to analyze health data, make informed decisions, and automate processes with minimal human intervention. For example, in October 2023, ZS, a US-based technology firm, launched the ZAIDYN Connected Health solution. This platform delivers trusted, AI-driven insights to pharmaceutical companies, healthcare providers, and payers, helping them address unmet medical needs and improve patient outcomes. ZAIDYN’s health insights suite identifies care gaps and offers personalized recommendations for physicians, patients, and manufacturers to enhance treatment access and coordination. Its patient engagement suite customizes support based on individual patient needs to increase the effectiveness of patient programs. Additionally, the connected research component uses advanced digital engagement tools to collect reliable evidence that assists healthcare organizations in validating innovations and guiding strategic decisions.
In September 2024, Stryker Corporation, a U.S.-based provider of medical technologies spanning surgical equipment, hospital systems, and connected medical devices, acquired care.ai for an undisclosed amount. Through this acquisition, Stryker sought to strengthen its connected medical device portfolio by integrating AI-driven hospital monitoring and workflow solutions to improve clinical efficiency and patient safety. Care.ai is a U.S.-based company that delivers AI-assisted virtual care platforms, smart-room ambient intelligence, and sensor-based patient monitoring solutions.
Major companies operating in the connected medical device market are Johnson and Johnson, Abbott Laboratories, Medtronic plc, F Hoffmann La Roche Ltd, Siemens Healthineers AG, Fresenius Medical Care AG and Co KGaA, Becton Dickinson and Company, Koninklijke Philips NV, GE Healthcare Technologies Inc, Boston Scientific Corporation, Baxter International Inc, Olympus Corporation, Terumo Corporation, Garmin Ltd, ResMed Inc, Omron Healthcare Inc, Epitel Inc, Masimo Corporation, AliveCor Inc, DexCom Inc, Insulet Corporation, iRhythm Technologies Inc.
North America was the largest region in the connected medical device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the connected medical device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the connected medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the connected medical device market by increasing the cost of imported components such as sensors, wireless modules, and connectivity chips. Segments like wearable and implantable devices are particularly impacted, with regions like Asia-Pacific including China and India experiencing significant import duties. This has led to higher production costs and potential delays in device deployment. Positively, tariffs are encouraging local component manufacturing, fostering innovation, and reducing long-term dependency on international supply chains.
The connected medical device market research report is one of a series of new reports that provides connected medical device market statistics, including connected medical device industry global market size, regional shares, competitors with a connected medical device market share, detailed connected medical device market segments, market trends and opportunities, and any further data you may need to thrive in the connected medical device industry. This connected medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A connected medical device is a digitally integrated healthcare instrument that communicates and exchanges data with other systems or networks via wireless or wired connections. These devices are designed to collect, transmit, and sometimes analyze health-related data in real time or over designated periods, allowing for continuous monitoring and timely medical insights.
Key types of connected medical devices include wearable, implantable, and stationary devices. Wearable devices are electronic gadgets worn on the body, such as smartwatches or fitness trackers, that monitor health metrics like heart rate, activity levels, and sleep patterns. They utilize various connectivity technologies including Bluetooth, Wi-Fi, cellular, and others. These devices are used for remote patient monitoring, telemedicine, clinical decision support, chronic disease management, fitness and wellness, among other applications. They serve a range of end users, including hospitals and clinics, home care environments, long-term care facilities, ambulatory surgical centers, and more.
The connected medical device market consists of sales of remote monitoring systems, connected imaging systems, smart drug delivery systems, and IoT-enabled surgical tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Connected Medical Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses connected medical device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for connected medical device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The connected medical device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Wearable Devices; Implantable Devices; Stationary Devices2) By Connectivity Technology: Bluetooth; Wi-Fi; Cellular; Other Connectivity Technologies
3) By Application: Remote Patient Monitoring; Telemedicine; Clinical Decision Support; Chronic Disease Management; Fitness And Wellness; Other Applications
4) By End-User: Hospitals And Clinics; Home Care Settings; Long-Term Care Facilities; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Wearable Devices: Fitness Trackers; Smartwatches; Continuous Glucose Monitors (CGM); Wearable ECG Monitors; Blood Pressure Monitors; Pulse Oximeters; Sleep Trackers2) By Implantable Devices: Cardiac Pacemakers; Implantable Cardioverter Defibrillators (ICDs); Neurostimulators; Cochlear Implants; Implantable Glucose Sensors; Drug Delivery Implants
3) By Stationary Devices: Remote Patient Monitoring Stations; Telehealth Kiosks; Connected Imaging Devices; Connected Ventilators; Connected Dialysis Machines; Connected Infusion Pumps
Companies Mentioned: Johnson and Johnson; Abbott Laboratories; Medtronic plc; F Hoffmann La Roche Ltd; Siemens Healthineers AG; Fresenius Medical Care AG and Co KGaA; Becton Dickinson and Company; Koninklijke Philips NV; GE Healthcare Technologies Inc; Boston Scientific Corporation; Baxter International Inc; Olympus Corporation; Terumo Corporation; Garmin Ltd; ResMed Inc; Omron Healthcare Inc; Epitel Inc; Masimo Corporation; AliveCor Inc; DexCom Inc; Insulet Corporation; iRhythm Technologies Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Connected Medical Device market report include:- Johnson and Johnson
- Abbott Laboratories
- Medtronic plc
- F Hoffmann La Roche Ltd
- Siemens Healthineers AG
- Fresenius Medical Care AG and Co KGaA
- Becton Dickinson and Company
- Koninklijke Philips NV
- GE Healthcare Technologies Inc
- Boston Scientific Corporation
- Baxter International Inc
- Olympus Corporation
- Terumo Corporation
- Garmin Ltd
- ResMed Inc
- Omron Healthcare Inc
- Epitel Inc
- Masimo Corporation
- AliveCor Inc
- DexCom Inc
- Insulet Corporation
- iRhythm Technologies Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 65.78 Billion |
| Forecasted Market Value ( USD | $ 117.68 Billion |
| Compound Annual Growth Rate | 15.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |

